Venkatasai Agencies Drugs Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 5.51 Cr
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.00 Cr
About Venkatasai Agencies Drugs
Venkatasai Agencies Drugs Private Limited (VADPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 March 2022 (Two years and 11 months 6 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.51 Cr.
The company currently has active open charges totaling ₹12.00 Cr.
Srinivas Bejgam, Narasaiah Arigela, and Aneesh Bejgam serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TG2022PTC160662
- Company No.
160662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2022
- Date of AGM
08 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Venkatasai Agencies Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Bejgam  | Managing Director | 17-Mar-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narasaiah Arigela | Director | 09-Jan-2024 | Current |
| Aneesh Bejgam | Director | 17-Mar-2022 | Current |
Financial Performance of Venkatasai Agencies Drugs.
Venkatasai Agencies Drugs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Venkatasai Agencies Drugs?
In 2023, Venkatasai Agencies Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medchem International India Private LimitedSrinivas Bejgam is a mutual person
Indian Hospitex Private LimitedNarasaiah Arigela is a mutual person
Vasu Organics Private LimitedSrinivas Bejgam and Aneesh Bejgam are mutual person
Vasu Vaccines And Speciality Drugs Hyd Private LimitedSrinivas Bejgam and Narasaiah Arigela are mutual person
- New Viswabharathy Drug Lines Private Limited
Narasaiah Arigela is a mutual person
- Auspharma Private Limited
Narasaiah Arigela is a mutual person
Charges (Loans)
₹12.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 12.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2023 | Hdfc Bank Limited | ₹12.00 Cr | Open |
How Many Employees Work at Venkatasai Agencies Drugs?
Venkatasai Agencies Drugs has a workforce of 57 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venkatasai Agencies Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venkatasai Agencies Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.